Buy Odomzo (sonidegib) Online
DISEASE INDICATIONS: Skin Cancer MANUFACTURER: Sun Pharmaceutical Industries Europe B.V. USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Therapeutic Goods Administration (TGA) Odomzo (sonidegib) is a medication used to treat locally advanced basal cell carcinoma (BCC). It is taken once daily at two possible dosages - 200mg or 800mg.
$5,478.00
Select optionsThis product has multiple variants. The options may be chosen on the product page